That's how I assume they're managing any data that is unrelated to Covid. They're seizing an opportunity with Covid to generate as much exposure as possible while saving lives and generating a potential revenue source. Any other study is progressing and data is being compiled and analyzed albeit probably at a slower rate.

I don't have any reason to expect the cancer results to be any less impressive than what we've seen so far.